Back to News
Top StoriesMarketWatch5h ago

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.

Read Full Article on MarketWatch

Content sourced from MarketWatch. Not financial advice.